ClinicalTrials.Veeva

Menu

Comparison of the Substitution Between Different Tobacco/Nicotine Products as a Function of Tobacco-user Type

Virginia Polytechnic Institute and State University logo

Virginia Polytechnic Institute and State University

Status

Completed

Conditions

Cigarette Smoking
Nicotine Vaping

Treatments

Other: Nicotine vaping products at 2x market price
Other: Nicotine pouch products at 1/2 market price.
Other: Heated tobacco products at 1/2 market price.
Other: Nicotine pouch products at 2x market price.
Other: Nicotine vaping products at 1/2 market price
Other: All nicotine/ tobacco products at market price
Other: Heated tobacco products at 2x market price.

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05177848
5P01CA200512 (U.S. NIH Grant/Contract)
IRB #21-1046

Details and patient eligibility

About

This study will investigate the relative appeal (abuse liability) of novel tobacco products, how the appeal is modulated by relative price, user type, and how novel products may substitute for one another.

Full description

An important aim of tobacco control is to reduce demand for the most harmful products. Therefore, a priori knowledge of substitutability across novel and widely used tobacco products may forecast the impact of policies on product switching. This study will use a novel method, the Experimental Tobacco Marketplace (ETM), to characterize the relative substitutability and appeal (abuse liability) of tobacco products (e.g., conventional cigarettes, nicotine vaping products [NVP], heated tobacco products [HTP], and nicotine pouch products [NPP]), and how the appeal is modulated by relative price and user type. Exclusive cigarette smokers and dual cigarette/NVP users, stratified by age, will complete multiple scenarios in the ETM.

Enrollment

60 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Provide informed consent
  • Be at least 21 years of age or older
  • Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm)
  • Stable tobacco use patterns for at least three months
  • Be willing to sample NVPs, HTPs, and NPPs
  • For exclusive cigarette smokers: smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month)
  • For dual cigarette/NVP users: smoke at least 5 cigarettes daily and use NVPs for at least 3 times in a week (report use of closed nicotine salt system)

Exclusion criteria

  • Have plans to move out of the area
  • Have a serious or unstable physical or mental health condition
  • Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement
  • Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Exclusive cigarette smokers
Experimental group
Description:
Exclusive cigarette smokers will be recruited and will be exposed to all of the conditions described in the intervention section.
Treatment:
Other: Heated tobacco products at 2x market price.
Other: All nicotine/ tobacco products at market price
Other: Nicotine vaping products at 1/2 market price
Other: Nicotine pouch products at 2x market price.
Other: Heated tobacco products at 1/2 market price.
Other: Nicotine pouch products at 1/2 market price.
Other: Nicotine vaping products at 2x market price
Dual cigarette/ nicotine vaping product users
Experimental group
Description:
Dual cigarette and nicotine vaping product users will be recruited and will be exposed to all of the conditions described in the intervention section.
Treatment:
Other: Heated tobacco products at 2x market price.
Other: All nicotine/ tobacco products at market price
Other: Nicotine vaping products at 1/2 market price
Other: Nicotine pouch products at 2x market price.
Other: Heated tobacco products at 1/2 market price.
Other: Nicotine pouch products at 1/2 market price.
Other: Nicotine vaping products at 2x market price

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Roberta Freitas Lemos, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems